GLP-1 medications can be highly effective, but drug persistence is often low, making them an unsustainable long-term treatment for many patients
Receive your first dose Your plan may include GLP-1s, oral medication, or a combination of both
GLP-1 receptor agonists bind to and activate GLP-1 receptors located throughout the body, particularly in pancreatic beta cells, the gastrointestinal tract, and the central nervous system
465 (Fig
These medications include GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy, Rybelsus) and liraglutide, as well as dual GIP/GLP-1 receptor agonists like tirzepatide (Mounjaro, Zepbound)
Fertility Potential GHKCu displays potential for males, enhancing sperm motility and quality in preclinical research, and females, supporting ovarian tissue recovery and endometrial health